AG-13958
AG-13958 (AG-013958), a VEGFR tyrosine kinase inhibitor, is in clinical development with ST administration for treatment of choroidal neovascularization associated with age–related macular degeneration (AMD).
| Trivial name | AG-013958 |
| Catalog Number | S2211 |
| Molecular Formula | C28H24Cl2FN5O2 |
| CAS# | 319460-94-1 |
| Inchi | InChI=1S/C28H24Cl2FN5O2/c1-2-8-24(35(16-7-15-32)27(37)21-11-6-12-22(30)25(21)31)26-33-23-17-18(29)13-14-20(23)28(38)36(26)34-19-9-4-3-5-10-19/h1,3-6,9-14,17,24,34H,7-8,15-16,32H2/t24-/m1/s1 |
| Inchi Key | UPJSUQWHUVLLNW-XMMPIXPASA-N |
| SMILES | C#CCC(C1=NC2=C(C=CC(=C2)Cl)C(=O)N1NC3=CC=CC=C3)N(CCCN)C(=O)C4=C(C(=CC=C4)Cl)F |
| Size | 2mg |
| Supplier Page | http://www.selleckchem.com/products/ag-13958.html |
| Additional Information | https://file.selleck.cn/downloads/struct/ag-13958-chemical-structure-s2211.gif |